July 14, 2025 · Form 4 insider transaction
Tsuchimoto Kim R sold 4,704 shares of MONOPAR THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 2 days after the transaction.
Reflects options to purchase a total of 4,704 shares of common stock granted to Ms. Tsuchimoto on February 20, 2017, for her services as a director and prior officer of Monopar Therapeutics. The options vested 6/48ths upon the 6-month anniversary of the grant date and 1/48th per month thereafter.